Calcitonin is a hormone produced by the parafollicular cells of the thyroid gland. Like calcium salts, calcitonin acts by reducing bone resorption. In this study, 26 osteoporotic patients were given 100 III salmon calcitonin for 10 days and, thereafter, 100 IU calcitonin every other day for 80 days combined with 1000 mg/day calcium salts. Prior to and after the combined therapy, the mean trabecular bone densities from the levels of thoracic 12 and lumbar 1 and 2 were obtained and routine thoracic and lumbar radiography performed. Combined calcitonin and calcium therapy for 3 months produced significant increases in vertebra trabecular bone density. The evaluation of the trabecular bone density and the number of non-traumatic compression fractures in 26 osteoporotic patients prior to the therapy did not indicate any close relationship between them. It is concluded that, in addition to other factors reported previously, microtraumas during daily activities have some effect on the incidence of fractures.
GonzalesDCMautalenCA: Failure of oral calcium to enhance the acute antiosteolytic effect of calcitonin. Calcif Tissue Int1987; 40: 114–115.
2.
HahnBH: Osteopenic bone diseases. In: Arthritis and Allied Conditions (McCarthyDJ, ed). Philadelphia, Lea & Febiger, 1985; pp 1579–1606.
3.
RaiszLGSmithJ: Prevention and therapy of osteoporosis. Ration Drug Ther1985; 8: 1–6.
4.
SilverbergSJLindsayR: Postmenopausal osteoporosis. Med Clin North Am1987; 1: 41–57.
5.
NordinBECNeedAGMorrisHA: New approaches to the problems of osteoporosis. Clin Orthop1985; 200: 181–193.
6.
MariePJCaulinF: Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis. Bone1986; 7: 17–22.
7.
AurbachGDMarxSJSpiegelAM: Metabolic bone diseases. In: William's Textbook of Endocrinology (WilsonJDFosterDW, eds). Philadelphia; WB Saunders, 1985; pp 1218–1255.
8.
McKennaMJFrameB: Hormonal influences on osteoporosis. Am J Med1987; 82 (suppl 18): 61–67.
9.
LindsayR: The risks and benefits of estrogen therapy in the immediate postmenopausal period. In: Osteoporosis (CohnDVMartinTJ, eds). Amsterdam: Elsevier, 1987; pp 17–20.
10.
AvioliLV: Calcitonin in postmenopausal and senile osteoporotic syndromes. In: Osteoporosis (CohnDVMartinTJ, eds). Amsterdam: Elsevier, 1987; pp 27–34.
11.
StevensonJC: Potentials of estrogen and calcitonin therapy in peri-menopausal females. In: Osteoporosis (CohnDVMartinTJ, eds). Amsterdam: Elsevier, 1987; pp 41–43.
12.
AvioliLV: Calcitonin therapy for bone diseases and hypercalcemia. Arch Intern Med1982; 142: 2076–2079.
13.
AurbachGDMarxSJSpiegelAM: Parathyroid hormone, calcitonin and the calciferols. In: William's Textbook of Endocrinology (WilsonJDFosterDW, eds). Philadelphia, WB Saunders, 1985; pp 1137–1217.
14.
GruberHEIveyJLBaylinkDJ: Long term calcitonin therapy in postmenopausal osteoporosis. Metabolism1984; 4: 295–303.
15.
MonsourPASmidJRKrugerBJ: The effect of intravenous sodium fluoride and synthetic salmon calcitonin on plasma total calcium, in organic phosphate and ionic fluoride. Calcif Tissue Int1987; 41: 105–111.
16.
MazzuoliGFValtortaCMinisolaS: Metabolic and bone effects of salmon calcitonin in postmenopausal osteoporosis. In: Osteoporosis (CohnDVMartinTJ, eds). Amsterdam: Elsevier, 1987; pp 35–40.
17.
GruberHEBaylinkDJ: The diagnosis of osteoporosis. J Am Geriatr Soc1981; 11: 490–497.
18.
GenantHKBlockJESteigerP: Quantitative computed tomography in assessment of osteoporosis. Semin Nucl Med1987; 4: 316–333.
19.
GoodwinPN: Methodologies for the measurement of bone density and their precision and accuracy. Semin Nucl Med1987; 4: 293–304.
20.
GenantHKCannCEEttingerB: Quantitative computed tomography of vertebral spongiosa. Ann Intern Med1982; 97: 699–705.
21.
SambrookPNBarletCEvansR: Measurement of lumbar spine bone mineral. Br J Radiol1985; 58: 621–624.
22.
PacificiRSusmanNCarrPL: Single and dual energy tomographic analysis of spinal trabecular bone. J Clin Endocrinol Metab1987; 2: 209–214.
23.
SchwartzmanMSFranckWA: Vitamin D toxicity complicating the treatment of senile, postmenopausal and glucocorticoid induced osteoporosis. Am J Med1987; 82: 224–230.
24.
SmithR: Osteoporosis. Br Med J1987; 294: 329–332.
25.
AloiaJFVaswaniAKapoorA: Treatment of osteoporosis with calcitonin with and without growth hormone. Metabolism1985; 34: 124–129.
26.
RuegseggerPDambacherMARuegseggerMS: Bone loss in premenopausal and postmenopausal women. J Bone Joint Surg (Am)1984; 7: 1015–1023.
27.
WahnerHW: Diagnosis of osteoporosis. Physician Sportsmed1987; 11: 73–79.
28.
FraioliFFabbriAGnessiL: Calcitonin and analgesia. Adv Pain Res Ther1984; 7: 237–250.
29.
SimkinAAyalonJLeichterI: Increased trabecular bone density due to bone loading exercises in postmenopausal osteoporotic women. Calcif Tissue Int1987; 49: 59–63.
30.
ChowRKHarrisonJEBrownCF: Physical fitness effect of bone mass in postmenopausal women. Arch Phys Med Rehabil1986; 67: 231–234.
31.
ThiebaudDBurckhardtPJaegerP: Effectiveness of salmon calcitonin administered as suppositories in tumor induced hypercalcemia. Am J Med1987; 82: 745–749.
